A survey of bloodborne viruses and associated risk behaviours in Greek prisons.
To determine HIV and hepatitis infection prevalence and correlates with risk behaviour.
Cross-sectional study :
Voluntary. anonymous HIV, hepatitis (HCV, HBVand HDV) surveillance and questionnaire on risk factors.
Korydallos Prison, Athens and Ag.
Stefanos Prison, Patra, Greece.
Of 544 drug users imprisoned for drug related offences, all completed the questionnaire and 533 blood samples were collected.
HIV (by anti-HIV-1), HCV (by anti-HCV, HBV (by anti-HBc, HBSAg) and HDV (by anti-HDV) prevalence.
Data on demography, legal status, drug use, sharing of injecting equipment.
Of the 544 drug users, 375 (68.9%) had injected drugs (IDUs) at some time, 35% of whom had injected whilst in that prison.
Of the 533 blood samples tested, one was positive for anti-HIV-1 (0.19%), 310 for anti-HCV (58.2%), 306/531 (57.6%) for anti-HBc, 34/527 (6.5%) for HBsAg and 12/527 (2.3%) for anti-HDV Prevalence rates for IDUs only were 0. 27% for HIV-1,80. 6% for hepatitis C, 62. 7% for hepatitis B and 3.3% for hepatitis D. Ninety-two per cent of IDUs injecting in prison shared needles, indicating that IDUs inject less but share more during incarceration.
Multiple logistic regression revealed needle-sharing as the most important risk factor for HCV infection in ID Us.
Prior knowledge of a positive hepatitis result did not appear to inhibit IDUs from practising risky behaviours in prison. (...)
Mots-clés Pascal : SIDA, Virose, Infection, Asymptomatique, Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Hépatite virale, Facteur risque, Milieu carcéral, Grèce, Europe, Prise risque, Toxicomanie, Voie intraveineuse, Partage, Seringue, Homme, Immunopathologie, Immunodéficit, Appareil digestif pathologie, Foie pathologie
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Asymptomatic, Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Viral hepatitis, Risk factor, Carceral environment, Greece, Europe, Risk taking, Drug addiction, Intravenous administration, Sharing, Syringe, Human, Immunopathology, Immune deficiency, Digestive diseases, Hepatic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0162006
Code Inist : 002B05C02D. Création : 21/07/1998.